Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial
- Kazuhiko Nakagawa
- , Edward B. Garon
- , Takashi Seto
- , Makoto Nishio
- , Santiago Ponce Aix
- , Luis Paz-Ares
- , Chao Hua Chiu
- , Keunchil Park
- , Silvia Novello
- , Ernest Nadal
- , Fumio Imamura
- , Kiyotaka Yoh
- , Jin Yuan Shih
- , Kwok Hung Au
- , Denis Moro-Sibilot
- , Sotaro Enatsu
- , Annamaria Zimmermann
- , Bente Frimodt-Moller
- , Carla Visseren-Grul
- , Martin Reck
研究成果: ジャーナルへの寄稿 › 学術論文 › 査読
552
リンクは新しいタブで開きます
被引用数
(Scopus)